167 related articles for article (PubMed ID: 38093288)
1. Hsa_circ_0136666 stimulates gastric cancer progression and tumor immune escape by regulating the miR-375/PRKDC Axis and PD-L1 phosphorylation.
Miao Z; Li J; Wang Y; Shi M; Gu X; Zhang X; Wei F; Tang X; Zheng L; Xing Y
Mol Cancer; 2023 Dec; 22(1):205. PubMed ID: 38093288
[TBL] [Abstract][Full Text] [Related]
2. Circular RNA hsa_circ_0067842 facilitates tumor metastasis and immune escape in breast cancer through HuR/CMTM6/PD-L1 axis.
Li J; Dong X; Kong X; Wang Y; Li Y; Tong Y; Zhao W; Duan W; Li P; Wang Y; Wang C
Biol Direct; 2023 Aug; 18(1):48. PubMed ID: 37592296
[TBL] [Abstract][Full Text] [Related]
3. N
Liu Z; Wang T; She Y; Wu K; Gu S; Li L; Dong C; Chen C; Zhou Y
Mol Cancer; 2021 Aug; 20(1):105. PubMed ID: 34416901
[TBL] [Abstract][Full Text] [Related]
4. Hsa_circ_0136666 activates Treg-mediated immune escape of colorectal cancer via miR-497/PD-L1 pathway.
Xu YJ; Zhao JM; Gao C; Ni XF; Wang W; Hu WW; Wu CP
Cell Signal; 2021 Oct; 86():110095. PubMed ID: 34320370
[TBL] [Abstract][Full Text] [Related]
5. Hsa_circ_0046523 Mediates an Immunosuppressive Tumor Microenvironment by Regulating MiR-148a-3p/PD-L1 Axis in Pancreatic Cancer.
Fu X; Sun G; Tu S; Fang K; Xiong Y; Tu Y; Zha M; Xiao T; Xiao W
Front Oncol; 2022; 12():877376. PubMed ID: 35712476
[TBL] [Abstract][Full Text] [Related]
6. Circ-METTL15 contributes to the proliferation, metastasis, immune escape and restrains apoptosis in lung cancer by regulating miR-1299/PDL1 axis.
Zhang R; Shang L; Nan J; Niu K; Dai J; Jin X; Zhang X
Autoimmunity; 2022 Feb; 55(1):8-20. PubMed ID: 34796777
[TBL] [Abstract][Full Text] [Related]
7. CircRNA VIM silence synergizes with sevoflurane to inhibit immune escape and multiple oncogenic activities of esophageal cancer by simultaneously regulating miR-124/PD-L1 axis.
Gao C; Xu YJ; Qi L; Bao YF; Zhang L; Zheng L
Cell Biol Toxicol; 2022 Oct; 38(5):825-845. PubMed ID: 34018092
[TBL] [Abstract][Full Text] [Related]
8. Circular RNA circ-CPA4/ let-7 miRNA/PD-L1 axis regulates cell growth, stemness, drug resistance and immune evasion in non-small cell lung cancer (NSCLC).
Hong W; Xue M; Jiang J; Zhang Y; Gao X
J Exp Clin Cancer Res; 2020 Aug; 39(1):149. PubMed ID: 32746878
[TBL] [Abstract][Full Text] [Related]
9. CircSCUBE3 Reduces the Anti-gastric Cancer Activity of Anti-PD-L1.
Shan H; Zhang X; Zhang X; Wei Y; Meng L; Li J; Zhang Z; Ma L; Xiao Y
Mol Biotechnol; 2024 Jan; 66(1):123-137. PubMed ID: 37052807
[TBL] [Abstract][Full Text] [Related]
10. Circular RNA hsa_circ_0068252 Functions in Cisplatin Resistance and Immune Response via miR-1304-5p/PD-L1 Axis in Non-Small Cell Lung Cancer.
Li J; Xu J; Wu G; Ren Y; Wang X; Zhang Q
Chemotherapy; 2022; 67(4):223-233. PubMed ID: 35649347
[TBL] [Abstract][Full Text] [Related]
11. Circular RNA hsa_circ_0000190 Facilitates the Tumorigenesis and Immune Evasion by Upregulating the Expression of Soluble PD-L1 in Non-Small-Cell Lung Cancer.
Luo YH; Yang YP; Chien CS; Yarmishyn AA; Adekunle Ishola A; Chien Y; Chen YM; Tsai PH; Lin TW; Wang ML; Chiou SH
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008490
[TBL] [Abstract][Full Text] [Related]
12. Circ_0010235 facilitates lung cancer development and immune escape by regulating miR-636/PDL1 axis.
Zhao J; Yan W; Huang W; Li Y
Thorac Cancer; 2022 Apr; 13(7):965-976. PubMed ID: 35167195
[TBL] [Abstract][Full Text] [Related]
13. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
[No Abstract] [Full Text] [Related]
14. Circular RNA hsa_circ_0005239 contributes to hepatocellular carcinoma cell migration, invasion, and angiogenesis by targeting the miR-34a-5p/PD-L1 axis.
He T; Huang J; Liang H; Zhong B; Xu G; Zhu X
Cell Biol Int; 2023 Sep; 47(9):1519-1534. PubMed ID: 37208963
[TBL] [Abstract][Full Text] [Related]
15. Circular RNA hsa-circ-0007766 modulates the progression of Gastric Carcinoma via miR-1233-3p/
Xu W; Zhou B; Wu J; Jiang P; Chen H; Yan F
Int J Med Sci; 2020; 17(11):1569-1583. PubMed ID: 32669960
[TBL] [Abstract][Full Text] [Related]
16. Circ_0008287 promotes immune escape of gastric cancer cells through impairing microRNA-548c-3p-dependent inhibition of CLIC1.
Li B; Liang L; Chen Y; Liu J; Wang Z; Mao Y; Zhao K; Chen J
Int Immunopharmacol; 2022 Oct; 111():108918. PubMed ID: 35905561
[TBL] [Abstract][Full Text] [Related]
17. circ-0000512 inhibits PD-L1 ubiquitination through sponging miR-622/CMTM6 axis to promote triple-negative breast cancer and immune escape.
Dong LF; Chen FF; Fan YF; Zhang K; Chen HH
J Immunother Cancer; 2023 Jun; 11(6):. PubMed ID: 37349124
[TBL] [Abstract][Full Text] [Related]
18. Hsa_circ_0020397 regulates colorectal cancer cell viability, apoptosis and invasion by promoting the expression of the miR-138 targets TERT and PD-L1.
Zhang XL; Xu LL; Wang F
Cell Biol Int; 2017 Sep; 41(9):1056-1064. PubMed ID: 28707774
[TBL] [Abstract][Full Text] [Related]
19. Hsa_circ_0003528 promotes cell malignant transformation and immune escape via increasing oncogene PDL1 through sponging miR-511-3p in non-small cell lung cancer.
Wang G; Deng L; Gong K; Zhou P; Peng L; Li C
Environ Toxicol; 2023 Jun; 38(6):1347-1360. PubMed ID: 36947452
[TBL] [Abstract][Full Text] [Related]
20. LncRNA MALAT1 promotes tumorigenesis and immune escape of diffuse large B cell lymphoma by sponging miR-195.
Wang QM; Lian GY; Song Y; Huang YF; Gong Y
Life Sci; 2019 Aug; 231():116335. PubMed ID: 30898647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
